Disc Medicine is laying off about 20% of its workforce after the Food and Drug Administration denied its application for accelerated approval of its bitopertin treatment.
The Active-L lumbar artificial disc is back on the U.S. market under Highridge Medical, and its first cases under the company were completed in February, Scott Blumenthal, MD, told Becker’s. Highridge ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results